India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:542812 has a market cap or net worth of INR 382.98 billion. The enterprise value is 399.23 billion.
| Market Cap | 382.98B |
| Enterprise Value | 399.23B |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
| Current Share Class | 109.85M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.30M |
Valuation Ratios
The trailing PE ratio is 61.57 and the forward PE ratio is 44.13.
| PE Ratio | 61.57 |
| Forward PE | 44.13 |
| PS Ratio | 7.91 |
| PB Ratio | 5.25 |
| P/TBV Ratio | 5.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 64.19 |
| EV / Sales | 8.25 |
| EV / EBITDA | 33.69 |
| EV / EBIT | 49.29 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.76 |
| Debt / FCF | n/a |
| Interest Coverage | 5.79 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.82% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 14.94M |
| Profits Per Employee | 1.92M |
| Employee Count | 3,242 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:542812 has paid 1.89 billion in taxes.
| Income Tax | 1.89B |
| Effective Tax Rate | 23.30% |
Stock Price Statistics
The stock price has increased by +5.39% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.39% |
| 50-Day Moving Average | 3,538.98 |
| 200-Day Moving Average | 3,840.78 |
| Relative Strength Index (RSI) | 46.42 |
| Average Volume (20 Days) | 5,694 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542812 had revenue of INR 48.42 billion and earned 6.22 billion in profits. Earnings per share was 56.64.
| Revenue | 48.42B |
| Gross Profit | 25.08B |
| Operating Income | 8.10B |
| Pretax Income | 8.11B |
| Net Income | 6.22B |
| EBITDA | 11.85B |
| EBIT | 8.10B |
| Earnings Per Share (EPS) | 56.64 |
Balance Sheet
The company has 5.01 billion in cash and 20.80 billion in debt, giving a net cash position of -15.79 billion.
| Cash & Cash Equivalents | 5.01B |
| Total Debt | 20.80B |
| Net Cash | -15.79B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 72.99B |
| Book Value Per Share | 660.36 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 51.80%, with operating and profit margins of 16.73% and 12.85%.
| Gross Margin | 51.80% |
| Operating Margin | 16.73% |
| Pretax Margin | 16.75% |
| Profit Margin | 12.85% |
| EBITDA Margin | 24.47% |
| EBIT Margin | 16.73% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 0.17% |
| Earnings Yield | 1.62% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |